Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • Vitamin D...

    Vitamin D supplementation beneficial for dry eye disease patients

    Written by Medha Baranwal Baranwal Published On 2019-06-02T19:15:22+05:30  |  Updated On 19 Aug 2021 4:43 PM IST

    Vitamin D supplements increase efficacy of lubricant eye preparations and help patients suffering from dry eye disease.


    The effect of topical carbomer-based lipid-containing artificial tears (CLAT) and hyaluronate (HU) in dry eye disease (DED) was dependent on serum 25-hydroxyvitamin D levels, and vitamin D supplementation enhanced the efficacy of topical lubricants for treatment of dry eye. These are the results from a retrospective, observational cohort study published in the journal Cornea.


    Vitamin D supplements prevent rickets in children and osteomalacia in adults. Together with calcium, vitamin D also helps protect older adults from osteoporosis.


    Vitamin D has other roles in the body, including modulation of cell growth, neuromuscular and immune function, and reduction of inflammation.




    Jin Sun Hwang, Department of Ophthalmology, Hallym University College of Medicine, Seoul, Korea, and colleagues conducted the study to investigate the efficacy of topical CLAT and HU in patients with dry eye disease (DED) based on serum 25-hydroxyvitamin D (25HD) levels and cholecalciferol (vitamin D) supplementation.



    Researchers evaluated 116 patients with DED, who were divided into vitamin D deficiency (VDD) group (<12 ng/mL; n=52) or non-VDD group (≥12 ng/mL; n=64) according to their serum 25HD levels. Based on patient's choice, they were randomly assigned to receive intramuscular (IM) vitamin D (200,000 IU) (VDD; n=46 and non-VDD; n=48) or 2000 IU oral vitamin D (VDD; n=5 and non-VDD; n=4).


    Patients who did not want to take any supplements were observed only with eye drops (n=8). Ocular surface disease index (OSDI) score, visual analog pain scale score, lid hyperemia, tear breakup time (TBUT), corneal fluorescein staining score and Schirmer test were compared between baseline and 2 weeks post-treatment after topical applications and between before and after cholecalciferol supplementation.



    Also Read: Long term Vitamin D supplementation decreases blood sugar levels in premenopausal women


    Key findings of the study include:


    • After 2 weeks, OSDI and visual analog pain scale scores decreased in both VDD and non-VDD groups after application of topical CLAT and HU compared with baseline.

    • There was no improvement in TBUT, corneal fluorescein staining score and lid hyperaemia from baseline in the VDD group by topical CLAT and HU, whereas those in the non-VDD group showed significant improvement from baseline (3.2 ± 1.7 vs 4.1 ± 2.2; 0.5 ± 0.7 vs 0.4 ± 0.6, and 2.2 ± 0.8 vs 1.9 ± 0.7, respectively).

    • There was a significant improvement in OSDI score, TBUT, and lid margin hyperemia in the IM group after cholecalciferol supplementation compared with pre-treatment (33.2 ± 23.2 vs 28.5 ± 21.9; 3.5 ± 1.9 vs 6.0 ± 2.5 and 2.2 ± 0.7 vs 1.2 ± 0.8).


    Also Read: Migraine patients at risk for dry eye: JAMA

    The vitamin D supplementation may relieve sign and symptoms on ocular surface in DED. It keeps the tear film and ocular surface smooth and healthy, as well as reduces inflammation," explained the authors, adding that, "The effect of topical lubricants depends on the serum 25HD levels. Vitamin D supplementation can be used as potential adjuvant therapy for patients with DED."


    For detailed study log on to 10.1097/ICO.0000000000001822

    cholecalciferolCornea journaldiseasedisorderdry eyedry eye diseaseEyeeye diseasehyaluronateJin Sun Hwanglipid containing artificial tearslubricantssupplementationtopical lubricantsVitamin DVitamin D Supplementation
    Source : With inputs from Cornea

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok